Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment.
Guerrero-Ochoa P, Ibáñez-Pérez R, Berbegal-Pinilla G, Aguilar D, Marzo I, Corzana F, Minjárez-Sáenz M, Macías-León J, Conde B, Raso J, Hurtado-Guerrero R, Anel A.
Guerrero-Ochoa P, et al. Among authors: raso j.
Biomedicines. 2022 May 24;10(6):1223. doi: 10.3390/biomedicines10061223.
Biomedicines. 2022.
PMID: 35740244
Free PMC article.